NCT07433699

Brief Summary

The objective of this study is to compare the effects of image-guided programming algorithm using various image segmentations vs standard clinical programming on reduction of tremor and patient satisfaction.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for phase_1

Timeline
15mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Apr 2026Aug 2027

First Submitted

Initial submission to the registry

February 19, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 30, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2027

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

February 19, 2026

Last Update Submit

February 19, 2026

Conditions

Keywords

Essential TremorDBSprogramming device

Outcome Measures

Primary Outcomes (1)

  • Tremor severity as measured by accelerometry

    1\. The Xsens MTw Awinda accelerometer will be used to measure tremor severity. Measurements will be taken at baseline (DBS off) and after each stimulation setting. The accelerometry data can be objectively measured by quantifying the frequency and amplitude of the tremors and has been shown to correlate with the CRST.

    1 Month

Secondary Outcomes (1)

  • Clinical measure of tremor severity - CRST

    1 month

Other Outcomes (2)

  • 3. Patient Global Impression of Change (PGIC) Scale

    1 month

  • 4. Quality of Life in Essential Tremor Questionnaire (QUEST)

    1 month

Study Arms (2)

Program A

OTHER

clinical-based standard settings

Device: programming a

Program B

EXPERIMENTAL

Image-guided programming

Device: programming b

Interventions

clinical based programming parameters

Program A

image-guided programming parameters

Program B

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients from 21-85 years of age
  • ET patients implanted with Boston Scientific DBS electrodes in the VIM thalamus
  • Proficiency with the English Language
  • Participant is able to comply with all testing and follow-up requirements as defined by the study protocol
  • Participant is able to provide voluntary decisionally capable, and appropriately informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neurosurgery Department Pennsylvania Hospital

Philadelphia, Pennsylvania, 19106, United States

Location

MeSH Terms

Conditions

Essential Tremor

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: On the study day, DBS will be temporarily switched off to obtain baseline tremor measurements. Tremor severity will be assessed using both quantitative accelerometry and standardized clinical rating scales. Participants will then undergo testing with two different DBS programming approaches: (1) their current clinically optimized program, and (2) an image-guided programming approach informed by VIM segmentation from established neuroanatomical atlases and reported DBS "sweet spots". For each programming condition, tremor severity will be assessed using accelerometry and clinical rating scales. At the conclusion of testing, both programs will be loaded onto the patient's device, and participants will be instructed to use each program for one week, and the patient can then select the desired program for the following two weeks. At the 1-month follow-up visit, participants will return for assessment of: (1) total time spent on each program, (2) patient preference for one program over t
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Neurosurgery

Study Record Dates

First Submitted

February 19, 2026

First Posted

February 25, 2026

Study Start

April 30, 2026

Primary Completion (Estimated)

May 30, 2027

Study Completion (Estimated)

August 30, 2027

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations